• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CP1

CANNPAL ANIMAL THERAPEUTICS LIMITED

0.00% ! 17.0¢
Currently unlisted. Proposed listing date: TBA
Add to My Watchlist

CannPal Animal Therapeutics Limited is an Australia-based pet pharmaceutical company. The... CannPal Animal Therapeutics Limited is an Australia-based pet pharmaceutical company. The Company is focused on research, developing and commercializing therapeutics for the companion animal health industry, using the compounds derived from the cannabis plants. It is focused on cats and dogs. Its lead drug candidate is CPAT-01, which targets osteosarcoma pain in dogs. It is also engaged in investigating and researching the ability to use cannabidiol derived from the hemp plant for developing a nutraceutical range of products for use in companion animals, including dogs, cats, birds, horses and other domestic animals, without a prescription. It is also developing pharmaceutical therapeutics for chronic pain and appetite stimulation. It is developing nutraceutical products for skin conditions, joint health and digestive health.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CP1
Ann: Implementation of Scheme of Arrangement 		18/03/21 0 809
18/03/21 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  809 
CP1
Ann: Removal from Official List 		18/03/21 0 786
18/03/21 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  786 
CP1
News: CP1 Auscann Says Cannpal Implemented Scheme Of Arrangement 		18/03/21 0 428
Metals & Mining SECTOR NEWS

Could this be the next U.S. Antimony Play?

Discover Utah Antimony right-arrow Created with Sketch.
RMX
16 Sep 2025
RED MOUNTAIN MINING LIMITED
18/03/21 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  428 
CP1
Ann: Implementation of CannPal Scheme of Arrangement 		18/03/21 0 527
18/03/21 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  527 
CP1
Ann: Suspension from Official Quotation 		17/03/21 6 3.4K
17/03/21 Last post  Furiousgeorge Comments Created with Sketch.  6  Views Created with Sketch.  3.4K 
CP1
Creso Pharma (ASX:CPH) eyes medicinal psychedelics market 		15/03/21 0 452
15/03/21 Last post  TheMarketOnline Comments Created with Sketch.  0  Views Created with Sketch.  452 
CP1
Ann: Change of Director's Interest Notice L Mills 		11/03/21 0 643
11/03/21 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  643 
CP1
Ann: Lodgement of Court Orders with ASIC 		11/03/21 0 585
11/03/21 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  585 

See All Discussions arrow Created with Sketch.

Featured News

FBM Assays confirm strong gold anomalism at Canyon within Miriam Project
right-arrow Created with Sketch.
RMX Red Mountain Secures Utah Antimony Project in United States
right-arrow Created with Sketch.
NEWS CLEO receives positive FDA feedback supporting ovarian cancer test pathway
right-arrow Created with Sketch.
3DA Amaero’s big move: Exclusive deal, big targets, and a lot on the line
right-arrow Created with Sketch.
NEWS Ausgold set to commence extensive multi-rig drilling campaign at Katanning
right-arrow Created with Sketch.
NEWS Cells protected by Xolatryp through mitochondrial stabilisation
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Top Stories

Future Battery Minerals identifies strong regolith gold anomalism at Canyon

Future Battery MD and CEO, Nick Rathjen, joins HotCopper to unpack the company's glittering assay results at its Miriam project.
Tuesday's HotCopper trends: Race Oncology, Paladin Energy, and other daily winners | Sep 16 Race Oncology has been trending on the HotCopper forums after the biotech firm submitted an intellectual property patent application.
Listen: HotCopper Wire Podcast 024 – Two '4D' stocks to watch, but only one winner In this HotCopper Wire Week 37 episode, we take a look at the Coles and Woolies legal fight and compare 4DMedical and 4DS Memory.
Market Close: Asian markets are visibly cautious, and gold profit-taking underscores that Good Afternoon and Welcome to HotCopper’s Market Close for Tuesday 16 September, I’m Jon Davidson. The index came back to life on Tuesday after Wall Street notched fresh records overnight, US futures just in the green once more in the final hour of trade. The next ...
Amaero's big move: Exclusive deal, big targets, and a lot on the line Amaero has just pulled off a deal that establishes its first-mover advantage: An exclusive five-year supply agreement with Titomic.

Featured News

NEWS Gateway acquires interest in strategic Glenburgh South Gold Project in WA
right-arrow Created with Sketch.
FBM Assays confirm strong gold anomalism at Canyon within Miriam Project
right-arrow Created with Sketch.
NEWS Where the Australian property market resurgence is heading and why it matters now
right-arrow Created with Sketch.
RMX Red Mountain Secures Utah Antimony Project in United States
right-arrow Created with Sketch.
NEWS CLEO receives positive FDA feedback supporting ovarian cancer test pathway
right-arrow Created with Sketch.
NEWS Cells protected by Xolatryp through mitochondrial stabilisation
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.